The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ...

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

And this will give them the best chance of improving the lives of people ... and highlight the ways we’re widening the search for new dementia treatments. Dr Emma Mead is from the Alzheimer’s Research ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Our medical tools and techniques are rapidly improving but our system for delivering health care is a source of widespread ...

Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.